Jazz Pharmaceuticals plc — Director's Dealing 2020

Nov 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2020-11-02

Reporting Person: O'Keefe Kenneth W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-02	Ordinary Shares	M	22249	—	Acquired	29667	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-02	Phantom Stock	$	M	22249	Disposed	2020-11-02	Ordinary Shares (22249)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	4445	Indirect

Footnotes

F1: On November 2, 2020, the Reporting Person's 22,249 phantom stock rights under the Issuer's Amended and Restated Directors Deferred Compensation Plan were settled for an equal number of the Issuer's ordinary shares.

F2: Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.